New CT and AI technologies in lung cancer screening at ESTI 2026
Join Canon Medical at the annual scientific meeting of the European Society of Thoracic Imaging (ESTI 2026) in Salzburg (June 04–06) for a focused symposium exploring how modern CT and AI technologies can help address these challenges across the lung cancer screening pathway – from image acquisition and reconstruction to analysis, reporting, and follow-up.
Across Europe, lung cancer screening (LCS) with low-dose CT is progressively expanding. As national programs are implemented and European initiatives support wider adoption, important challenges – such as ensuring diagnostic confidence at low dose, improving accessibility, supporting efficient workflows, and managing nodules and incidental findings – remain.
Mark your calendar and don’t miss our dedicated symposium, “New CT and AI technologies in Lung Cancer Screening: From Accessibility to Nodule Management,” on June 4, to learn more about the topic.
Canon Medical Academy
New CT and AI technologies in Lung Cancer Screening
June 04 | 12:05–13:05 | Room 1
Join the “New CT and AI technologies in Lung Cancer Screening” symposium
June 04, 12:05–13:05 | Room 1
Don’t miss the Canon Medical symposium at ESTI 2026, where leading experts will share their perspectives and experience on the topic.
The session will be moderated by Prof. Mathias Prokop and will feature presentations from Prof. Annemiek Snoeckx and Prof. Cornelia M. Schaefer-Prokop.
Program
- Introduction | Prof. Mathias Prokop
- Lung Cancer Screening in Motion: Access, Efficiency, Innovation | Prof. Annemiek Snoeckx
- How Technology Can Help in Nodule Management and Incidental Findings | Prof. Cornelia M. Schaefer-Prokop
- Live Q&A moderated by Prof. Mathias Prokop
- To learn how CT and AI can help improve accessibility and efficiency in LCS through faster workflows in image acquisition, analysis and reporting
- To discover the latest dose reduction technologies in CT, at both the hardware and software levels
- To learn how AI in image reconstruction and analysis can help in the management of nodules and incidental findings
Information on Speakers and Presentations
Moderator:
Prof. Mathias Prokop, MD, PhD
Radiologist, Professor and Chairman, Department of Medical Imaging
Radboud University Medical Center
Nijmegen, The Netherlands
Radboud University Medical Center
Nijmegen, The Netherlands
Speaker:
Prof. Annemiek Snoeckx, MD, PhD
Associate Professor, University of Antwerp; Head of the Radiology Department, Antwerp University Hospital
Antwerp University Hospital
Edegem, Belgium
Presentation: Lung Cancer Screening in Motion: Access, Efficiency, Innovation
While the value of lung cancer screening (LCS) in terms of mortality reduction has been demonstrated, its effective implementation still presents some challenges. These challenges are multiple and span over a wide range of complexities, from ensuring appropriate eligibility and equitable access, to improving efficiency through faster and automated workflows in image acquisition, analysis, and structured reporting. While increased awareness, educational programs, and logistic efforts are essential, current CT and AI technology may also play an important role in addressing some of these challenges.
In this presentation, an overview of the main challenges in lung cancer screening workflows will be outlined, and the potential role of CT and AI technologies in improving accessibility and efficiency will be discussed.
Antwerp University Hospital
Edegem, Belgium
Presentation: Lung Cancer Screening in Motion: Access, Efficiency, Innovation
While the value of lung cancer screening (LCS) in terms of mortality reduction has been demonstrated, its effective implementation still presents some challenges. These challenges are multiple and span over a wide range of complexities, from ensuring appropriate eligibility and equitable access, to improving efficiency through faster and automated workflows in image acquisition, analysis, and structured reporting. While increased awareness, educational programs, and logistic efforts are essential, current CT and AI technology may also play an important role in addressing some of these challenges.
In this presentation, an overview of the main challenges in lung cancer screening workflows will be outlined, and the potential role of CT and AI technologies in improving accessibility and efficiency will be discussed.
Speaker:
Prof. Cornelia M. Schaefer-Prokop, MD, PhD
Radiologist
Meander Medical Centre (and Radboud University Medical Center)
Amersfoort, the Netherlands
Presentation: How Technology Can Help in Nodule Management and Incidental Findings
Managing lung nodules and incidental findings deriving from low-dose CT in lung cancer screening (LCS) remains an important challenge. A balanced approach that avoids overdiagnosis while addressing clinically significant issues is essential to ensure the highest impact on individuals who have to be treated while maintaining a sustainable healthcare system. This presentation will discuss how CT technology can help in this direction, with a focus on the role of deep learning reconstruction for super-resolution imaging, Artificial Intelligence, and photon-counting detector CT.
Meander Medical Centre (and Radboud University Medical Center)
Amersfoort, the Netherlands
Presentation: How Technology Can Help in Nodule Management and Incidental Findings
Managing lung nodules and incidental findings deriving from low-dose CT in lung cancer screening (LCS) remains an important challenge. A balanced approach that avoids overdiagnosis while addressing clinically significant issues is essential to ensure the highest impact on individuals who have to be treated while maintaining a sustainable healthcare system. This presentation will discuss how CT technology can help in this direction, with a focus on the role of deep learning reconstruction for super-resolution imaging, Artificial Intelligence, and photon-counting detector CT.
Prof. Mathias Prokop
Mathias Prokop is Professor of Radiology and Chairman of the Department of Medical Imaging at Radboud University Medical Center in Nijmegen, the Netherlands. His department focuses on impactful innovations in care and now hosts one of the largest research groups in Europe.
For decades, he has been involved with many technological and clinical innovations in CT, from dual energy, spiral scanning, CTA, gated imaging, multidetector technology, dose reduction, low-kV scanning, to more recently, ultrahigh-resolution CT, image reconstruction, and photon-counting CT.
Prof. Annemiek Snoeckx
Annemiek Snoeckx, MD, PhD is an Associate Professor at the University of Antwerp and serves as Chair of the Radiology Department at Antwerp University Hospital in Belgium. Her clinical and research expertise centers on chest imaging, with a particular focus on thoracic oncology, including lung cancer, pulmonary nodules and lung cancer screening.
Prof. Snoeckx plays an active role in various professional societies, including ESR, ESTI, ERS. She authored or co-authored 100+ papers in peer-reviewed journals and has lectured at many national and international meetings and courses. She is principal investigator of the Flemish lung cancer screening implementation study ZORALCS.
Prof. Cornelia M. Schaefer-Prokop
Professor Cornelia Schaefer-Prokop works as a radiologist at Meander Medical Center in Amersfoort, in the Netherlands. Her research affiliations are with the Radboud University Medical Center in Nijmegen, the Netherlands and Hannover Medical School in Hannover, Germany.
Prof. Schaefer-Prokop is an expert in chest radiology with main research interests in computer-aided detection and classification, lung cancer screening, and interstitial lung diseases. She has served as President of the Fleischner Society and as President of the European Society of Thoracic Imaging.
For more information on lung cancer screening solutions, please visit here.
Disclaimers
- The opinions expressed in this material are solely those of the presenter and not necessarily those of Canon Medical Systems. Canon Medical Systems does not guarantee the accuracy or reliability of the information provided herein.
- The clinical results, performance and views described in this video/webinar are the experience of the clinician. Results may vary due to clinical setting, patient presentation and other factors. Many factors could cause the actual results and performance of Canon Medical’s products to be materially different from any of the aforementioned.
- Some products shown might not be available in all regulatory jurisdictions, please consult with your local Canon sales office for availability in your region.
Social Media
